Related Experiment Video
Updated: May 13, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
ConfDTI: Structure Confidence-Guided Multimodal Fusion for Drug-Target Interaction Prediction
Jiayin Song1, Feiyan Sun1, Yilei Shu1
1School of Computer Science and Technology, Shandong University of Technology, Zibo 255000, Shandong, China.
None:
Protein structural information provides critical physical constraints for drug-target interaction (DTI) prediction. However, predicted protein structures inherently exhibit structural uncertainty, and treating them as deterministic inputs may introduce noise and amplify errors during feature aggregation and cross-modal interaction, thereby compromising model generalization. To overcome this issue, we explicitly incorporate structural uncertainty into DTI prediction and propose ConfDTI, a structural-confidence-guided multimodal framework. ConfDTI leverages the AlphaFold2-derived confidence score, predicted local distance difference test (pLDDT), as a residue-level indicator of structural reliability and integrates it into both representation learning and cross-modal interaction. Specifically, structural confidence modulates attention during protein encoding and regulates modality contributions during fusion, enabling adaptive utilization of structural information according to its reliability. By unifying confidence-aware encoding and confidence-modulated fusion within a coherent framework, ConfDTI effectively mitigates the impact of unreliable structural signals and promotes robust interaction modeling. Experimental results on the DrugBank, Davis, and KIBA data sets demonstrate that ConfDTI consistently outperforms representative baselines in both predictive performance and cold-start generalization. Further ablation studies and mechanistic analyses confirm that modeling structural confidence is the primary factor driving these improvements.
Related Concept Videos
Protein-protein Interfaces
Quantitative Aspects of Drug-Receptor Interaction
Pharmacogenomics: Identification of New Drug Targets
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Tagging and Fusion Proteins
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...